2John Wahren. C - peptide: new findings and therapeutic implications in diabetes. Clinical Physilogy and Functionnal Imaging 2005:24(4), 180 - 189.
3Kunt T, Schneider S, Pfutzner A, et al. The effect of human proinsulin C - peptide on erythrocyte deformability in patients with typel diabetes mellitus. Diabetologia 2006;42(4) ;465 -471.
4Tsimaratos M Roger F, Chabardes D, et al C - peptide stimulates Na ^+ - K ^+ - ATPase activity vir PKC alpha in rat medullary thick ascending linb. Diabetotogia 2007 ;46 ( 1 ) : 124 - 131.
6Weir GC, Bonner-Weir S. Five stages of evolving β-cell dysfunction during progression to diabetes. Diabetes, 2004,53(Suppl 3):S16-S21.
7Porte D Jr. Banting lecture 1990. Beta-cells in type Ⅱ diabetes mellitus. Diabetes, 1991,40:166-180.
8Porksen N. The in vivo regulation of pulsatile insulin secretion. Diabetologia, 2002,45:3-20.
9Larsson H, Ahren B. Glucose-dependent arginine stimulation test for characterization of islet function: studies on reproducibility and priming effect of arginine. Diabetologia, 1998,41:772-777.
